SCHEMBL1876356

SCHEMBL1876356

CCOCOc1ccc(C(c2ccc(OCOCC)c(NC(=O)c3ccccc3)c2)(C(F)(F)F)C(F)(F)F)cc1NC(=O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.59
▸ HDAC1 Q13547 3/20 0.54
▸ HDAC8 Q9BY41 3/20 0.54
▸ HDAC6 Q9UBN7 3/20 0.54
▸ KDM4E B2RXH2 4/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ CYP1A2 P05177 2/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ ALDH1A1 P00352 3/20 0.47
▸ HPGD P15428 2/20 0.47
▸ MAPT P10636 4/20 0.47
▸ GAA P10253 2/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CREBBP Q92793 3/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ AHR P35869 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ EPHX1 P07099 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10027982 0.95 HTT (0.54) HTTHDAC1HDAC8HDAC6KDM4E
SCHEMBL413038 0.76 NPC1 (0.61) HDAC1HDAC8HDAC6KDM4EKMT2A
SCHEMBL8410525 0.75 HDAC1 (0.50) HDAC1HDAC8HDAC6KDM4EKMT2A
SCHEMBL1871490 0.74 HDAC1 (0.60) HTTHDAC1HDAC8HDAC6KMT2A
SCHEMBL14030980 0.74 RAB9A (0.52) HTTHDAC1HDAC8HDAC6KMT2A
SCHEMBL31511732 0.72 PTGS1 (0.46) HTTHDAC1HDAC8HDAC6KDM4E
SCHEMBL11328524 0.72 HDAC1 (0.72) HDAC1HDAC8HDAC6KDM4EKMT2A
SCHEMBL1756430 0.72 EPHX1 (0.77) HTTHDAC1HDAC8HDAC6KDM4E
SCHEMBL30434017 0.72 EPHX1 (0.77) HTTHDAC1HDAC8HDAC6KDM4E
SCHEMBL27230103 0.72 MAPT (0.66) HTTHDAC1HDAC8HDAC6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7939241-B2 (Meth)acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and patterning method NEC CORPORATION (JP) 2011-05-10 — — US disclosed
US-7939241-B2 (Meth)acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and patterning method NEC CORPORATION (JP) 2011-05-10 — — US disclosed
US-20090068587-A1 (Meth) acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and patterning method NEC CORPORATION (JP) 2009-03-12 — — US disclosed
US-20090068587-A1 (Meth) acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and patterning method NEC CORPORATION (JP) 2009-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090068587-A1 (Meth) acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and patterning method MMAB, DNMT3A, MAT1A HTT 350/4885HDAC1 2441/4885HDAC8 3821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback